Polen Capital Management
AGN

Polen Capital Management’s Allergan Inc AGN Stock Holding History

Polen Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,162,639
Closed -$247M – 24
2014
Q4 		$247M Sell
1,162,639
-1,284,736
-52% -$255M 5.09% 9
2014
Q3 		$436M Sell
2,447,375
-73,799
-3% -$12.3M 9.8% 1
2014
Q2 		$427M Sell
2,521,174
-127,490
-5% -$19.8M 9.32% 1
2014
Q1 		$329M Sell
2,648,664
-25,395
-0.9% -$3.09M 7.11% 3
2013
Q4 		$297M Sell
2,674,059
-118,421
-4% -$11.3M 6.57% 5
2013
Q3 		$253M Sell
2,792,480
-165,758
-6% -$14.9M 5.82% 7
2013
Q2 		$249M Buy
+2,958,238
New +$307M 5.93% 6

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Polen Capital Management's AGN Position: Q1 2015 in Review

Polen Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,162,639 shares — an estimated $247M sold.

Polen Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $436M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Polen Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Polen Capital Management sold 1,162,639 Allergan Inc shares in Q1 2015, an estimated $247M.
  • Polen Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Polen Capital Management's Allergan Inc position peaked at $436M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Polen Capital Management's 13F filing for Q1 2015, filed 15 May 2015.